Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MSOX
Upturn stock ratingUpturn stock rating

AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF (MSOX)

Upturn stock ratingUpturn stock rating
$6.87
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/16/2025: MSOX (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit -10.82%
Avg. Invested days 17
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/16/2025

Key Highlights

Volume (30-day avg) -
Beta -
52 Weeks Range 2.14 - 68.40
Updated Date 06/29/2025
52 Weeks Range 2.14 - 68.40
Updated Date 06/29/2025

ai summary icon Upturn AI SWOT

AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF

stock logo

ETF Overview

overview logo Overview

The AdvisorShares MSOS 2x Daily ETF (MSOX) seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the AdvisorShares Pure US Cannabis ETF (MSOS). It offers leveraged exposure to US cannabis companies, primarily those involved in multi-state operations.

reliability logo Reputation and Reliability

AdvisorShares is known for its actively managed ETFs, including those focusing on niche sectors. They have a mixed reputation due to the risk associated with leveraged ETFs.

reliability logo Management Expertise

AdvisorShares employs a team of experienced investment professionals focused on identifying and managing niche investment opportunities.

Investment Objective

overview logo Goal

To seek daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the AdvisorShares Pure US Cannabis ETF (MSOS).

Investment Approach and Strategy

Strategy: The ETF employs a leveraged strategy, aiming for 2x the daily performance of the MSOS ETF. This involves the use of financial instruments such as swaps and options.

Composition The ETF does not directly hold assets like stocks. Instead, it uses derivatives to gain leveraged exposure to the performance of the MSOS ETF, which holds cannabis stocks.

Market Position

Market Share: MSOX holds a small market share within the leveraged ETF category.

Total Net Assets (AUM): 29490000

Competitors

overview logo Key Competitors

  • MSOS

Competitive Landscape

The leveraged cannabis ETF market is extremely limited. MSOS is the primary competitor given it's the benchmark for this fund. MSOX provides amplified returns (and losses) compared to MSOS. This leverage can be an advantage in up markets but a significant disadvantage in down markets.

Financial Performance

Historical Performance: Historical performance data is subject to market fluctuations and the leveraged nature of the ETF, resulting in high volatility. (Performance data is not accessible)

Benchmark Comparison: The ETF aims to achieve 2x the daily performance of the MSOS ETF. Deviations can occur due to tracking error and compounding effects.

Expense Ratio: 1.54

Liquidity

Average Trading Volume

The ETF has a moderate average trading volume, which can impact the ease of buying and selling shares.

Bid-Ask Spread

The bid-ask spread can be relatively wide due to its leveraged nature and niche market focus, which can increase transaction costs.

Market Dynamics

Market Environment Factors

The ETF's performance is influenced by the regulatory environment surrounding cannabis, investor sentiment toward the cannabis industry, and broader market conditions.

Growth Trajectory

The growth trajectory is closely tied to the performance of the underlying MSOS ETF and investor appetite for leveraged cannabis exposure. Changes to the cannabis industry, such as federal legalization could positively impact the holdings.

Moat and Competitive Advantages

Competitive Edge

MSOX's competitive advantage lies in its offering of leveraged exposure to the U.S. cannabis sector. This appeals to investors seeking amplified returns, while also acknowledging heightened risks. It is a niche product and one of the few leveraged options in the cannabis space. The ETFu2019s success depends on the sustained growth of the U.S. cannabis market and precise tracking of its leveraged strategy.

Risk Analysis

Volatility

The ETF exhibits high volatility due to its leveraged strategy and the inherent volatility of the cannabis sector.

Market Risk

The ETF is subject to market risk related to fluctuations in cannabis stock prices, regulatory changes, and broader economic conditions. The leveraged nature amplifies these risks.

Investor Profile

Ideal Investor Profile

The ideal investor is an experienced trader with a high-risk tolerance, seeking short-term tactical exposure to the U.S. cannabis sector.

Market Risk

The ETF is best suited for active traders due to its leveraged structure and daily reset. It is not suitable for long-term, buy-and-hold investors.

Summary

AdvisorShares MSOS 2x Daily ETF (MSOX) offers a leveraged approach to investing in the U.S. cannabis market, seeking twice the daily returns of the AdvisorShares Pure US Cannabis ETF (MSOS). This ETF is tailored for experienced traders seeking short-term tactical exposure. Due to its leverage and volatility, it is not suited for long-term investors. The ETF's performance is highly dependent on the growth and regulatory landscape of the cannabis industry. Its high expense ratio and potential tracking error should also be carefully considered.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • AdvisorShares website
  • ETF.com
  • Bloomberg

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Investing in ETFs involves risk, including the potential loss of principal.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund will enter into one or more swap agreements intended to produce economically-leveraged investment results relative to the returns of the US Cannabis ETF. The US Cannabis ETF primarily invests in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies. The fund is non-diversified.